Guidance and strategies to streamline ethics review and oversight of COVID-19-related research, 7 April 2020
Gov't Doc #
MetadataShow full item record
Other Language Versions
Faced with the COVID-19 pandemic, we have the moral duty to conduct research that generates evidence to maintain, promote and improve health care delivery and decision-making, and to define policies for managing and mitigating the pandemic. In order to efficiently respond to this health emergency, it is necessary to adapt existing ethics review procedures and search for alternatives to reduce as much as possible the practical obstacles to conducting research. This document offers health authorities and ethics review committees guidance and strategies with which to implement rapid and rigorous ethics review and oversight processes for COVID-19-related research with human subjects.
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Showing items related by title, author, creator and subject.
Template and operational guidance for the ethics review and oversight of COVID-19-related research, 15 April 2020 Pan American Health Organization; Health Systems and Services (HSS) (Washington, D.C., PAHO, 2020-04-15)As part of the response to the COVID-19 pandemic, health research has proliferated. Clinical trials and other studies with human participants are being conducted to find efficacious treatments and vaccines for COVID-19. ...
Pan American Health Organization (Washington, D.C., PAHO, 2009)The purpose of these Standard Operating Procedures (SOPs) is to delineate the structure and process followed by the Ethics Review Committee of the Pan American Health Organization (PAHOERC) for review of proposals, including ...
Emergency Use of Unproven Interventions Outside of Research. Ethics Guidance for the COVID-19 Pandemic, 25 June 2020 Pan American Health Organization; Health Systems and Services (HSS) (Washington, D.C., PAHO, 2020-06-25)The COVID-19 pandemic presents us with the moral urgency to conduct rigorous research as soon as possible to produce evidence about the safety and efficacy of interventions to treat or prevent COVID-19. However, as in ...